{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:28:08Z","timestamp":1793600888165,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaad.2026.04.1979","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:51:28Z","timestamp":1777564288000},"page":"57-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The wide world of glucagon-like peptide-1 agonist therapy: The thrill of weight loss and the agony of alopecia"],"prefix":"10.1016","volume":"95","author":[{"given":"Warren R.","family":"Heymann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jaad.2026.04.1979_bib1","article-title":"Use of glucagon-like peptide-1 (GLP-1) agonists in modulating preexisting dermatologic disease: a systematic review","volume":"17","author":"Tassavor","year":"2025","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.jaad.2026.04.1979_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/00368504261444578","article-title":"GLP-1 therapies and hair loss: a systematic review of current evidence and implications for counseling","volume":"109","author":"Gupta","year":"2026","journal-title":"Sci Prog"},{"key":"10.1016\/j.jaad.2026.04.1979_bib3","article-title":"Alopecia after glucagon-like peptide-1 agonist therapy: a TriNetX Database active comparator retrospective cohort study","author":"Lauck","year":"2026","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2026.04.1979_bib4","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/ijd.17246","article-title":"GLP-1 agonists and hair loss: a call for further investigation","volume":"63","author":"Desai","year":"2024","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.04.1979_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.36849\/JDD.8605","article-title":"A retrospective comparative analysis of cutaneous adverse reactions in GLP-1 agonist therapies","volume":"24","author":"Daniel","year":"2025","journal-title":"J Drugs Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226025843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226025843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:45:13Z","timestamp":1793598313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226025843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0190962226025843"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.04.1979","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The wide world of glucagon-like peptide-1 agonist therapy: The thrill of weight loss and the agony of alopecia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.04.1979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}